Board of Trustees

The University of Chicago Cancer Research Foundation (UCCRF) is a private, not-for-profit organization that seeks funds to underwrite basic and clinical research programs on the causes, diagnosis, treatment and prevention of cancer at the University of Chicago Medicine Comprehensive Cancer Center. It was founded in 1946 by philanthropist Maurice Goldblatt and since its creation has raised over $100 million dollars to support innovative cancer research.

Led by President Margaret Benjamin, the UCCRF Board of Trustees is made up of the presidents of the subsidiary boards, representatives of other foundations, and distinguished philanthropists. This wealth of experience and knowledge provides counsel, guidance, and support for the UCCRF. The Board of Trustees builds a strong culture of philanthropy and supports all modalities of fundraising to ensure that the cancer faculty and researchers achieve their aspirations. They advocate on behalf of the Comprehensive Cancer Center, to increase local, regional, and national awareness and to enhance the public image as a leader in cancer research and patient care; advise the Dean of the University of Chicago Medicine and director of the Comprehensive Cancer Center on key institutional initiatives and recruits and maintains strong and vibrant boards.

The Foundation’s members are investors in innovation. The Board of Trustees provide the Comprehensive Cancer Center with funding that has a special value because it supports the preliminary research required to obtain financing from other sources. We raise the venture capital that gives scientists and clinicians the freedom to boldly pursue their most promising insights. By leveraging our contributions, the Comprehensive Cancer Center is able to create pioneering therapies and bring their enormous benefits to patients and communities. We see the impacts of contributions to the Foundation at work throughout the University.

The combined power of these donations—large and small—has enabled the purchase of state-of-the-art equipment, enhanced hospital and laboratory facilities, funded fellowships for young scientists, and generated innovative research by our most distinguished researchers. These scientists rely on this essential support because it provides them with the freedom necessary to pursue their most visionary investigations and explore new frontiers in cancer research.